BLUE WATER VACCIN.-00001
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly k… Read more
Market Cap & Net Worth: BLUE WATER VACCIN.-00001 (J4T)
BLUE WATER VACCIN.-00001 (F:J4T) has a market capitalization of $2.16 Million (€2.10 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #41821 globally and #6407 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BLUE WATER VACCIN.-00001's stock price €2.82 by its total outstanding shares 744752 (744.75K).
BLUE WATER VACCIN.-00001 Market Cap History: 2022 to 2024
BLUE WATER VACCIN.-00001's market capitalization history from 2022 to 2024. Data shows change from $30.12 Million to $2.16 Million (-91.43% CAGR).
BLUE WATER VACCIN.-00001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BLUE WATER VACCIN.-00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of J4T by Market Capitalization
Companies near BLUE WATER VACCIN.-00001 in the global market cap rankings as of March 19, 2026.
Key companies related to BLUE WATER VACCIN.-00001 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
BLUE WATER VACCIN.-00001 Historical Marketcap From 2022 to 2024
Between 2022 and today, BLUE WATER VACCIN.-00001's market cap moved from $30.12 Million to $ 2.16 Million, with a yearly change of -91.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €2.16 Million | -59.90% |
| 2023 | €5.38 Million | -82.15% |
| 2022 | €30.12 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 20th, 2025 the market cap of BLUE WATER VACCIN.-00001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.16 Million USD |
| MoneyControl | $2.16 Million USD |
| MarketWatch | $2.16 Million USD |
| marketcap.company | $2.16 Million USD |
| Reuters | $2.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.